256 related articles for article (PubMed ID: 34720564)
1. Bio-evaluation of fluoro and trifluoromethyl-substituted salicylanilides against multidrug-resistant
Lal J; Kaul G; Akhir A; Ansari SB; Chopra S; Reddy DN
Med Chem Res; 2021; 30(12):2301-2315. PubMed ID: 34720564
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
4. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA).
Gatadi S; Gour J; Kaul G; Shukla M; Dasgupta A; Akunuri R; Tripathi R; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2018 Dec; 81():175-183. PubMed ID: 30130650
[TBL] [Abstract][Full Text] [Related]
6. Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.
Mohammad H; Mayhoub AS; Cushman M; Seleem MN
J Antibiot (Tokyo); 2015 Apr; 68(4):259-66. PubMed ID: 25315757
[TBL] [Abstract][Full Text] [Related]
7. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
8. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
9. New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354.
Escobar IE; White A; Kim W; Mylonakis E
Antibiotics (Basel); 2020 Oct; 9(10):. PubMed ID: 33019726
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of vancomycin resistant
Hasan R; Acharjee M; Noor R
Ci Ji Yi Xue Za Zhi; 2016; 28(2):49-53. PubMed ID: 28757721
[TBL] [Abstract][Full Text] [Related]
11. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial evaluation of (E)-1-(1H-indol-3-yl) ethanone O-benzyl oxime derivatives against MRSA and VRSA strains.
Akunuri R; Veerareddy V; Kaul G; Akhir A; Unnissa T; Parupalli R; Madhavi YV; Chopra S; Nanduri S
Bioorg Chem; 2021 Nov; 116():105288. PubMed ID: 34454299
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of Methicillin and Vancomycin Resistant
Jahanshahi A; Zeighami H; Haghi F
Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
[No Abstract] [Full Text] [Related]
14. Antimicrobial and antibiofilm activities of Cu(II) Schiff base complexes against methicillin-susceptible and resistant Staphylococcus aureus.
Chung PY; Khoo REY; Liew HS; Low ML
Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):67. PubMed ID: 34560892
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
Fritsche TR; Rhomberg PR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):399-403. PubMed ID: 18178361
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536
[TBL] [Abstract][Full Text] [Related]
17. Methicillin-resistant
Okwu MU; Olley M; Akpoka AO; Izevbuwa OE
AIMS Microbiol; 2019; 5(2):117-137. PubMed ID: 31384707
[TBL] [Abstract][Full Text] [Related]
18. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
20. Multidrug and vancomycin resistance among clinical isolates of
Olufunmiso O; Tolulope I; Roger C
Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
